Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

Top Top
About the Journal

Journal of Cancer Metastasis and Treatment (JCMT) is an international peer-reviewed, open access, online journal.

Aims and Scope

The journal concerns cancer metastasis and treatment, including the occurrence, development, progression, metastasis, and treatment of neoplastic diseases. Its coverage includes basic, translational and clinical studies related to cancer cell biology, genomics, precision medicine, medical oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc. Articles in the following areas are especially welcome:

  • Basic research on cancer occurrence and progression, focusing on molecular biology, cell biology, and genetics;
  • Mechanisms of metastasis and its prevention and control;
  • Basic and clinical research on treatment of primary, metastatic tumors and the like;
  • Improved methods for medical, radiological, and/or surgical treatment of metastatic tumors (immunotherapy, chemotherapy, radiotherapy, biological therapy, operative treatment, interventional therapy, etc.);
  • Observational/epidemiological studies focusing on environmental and behavioral factors that reduce the risk of cancer progression and metastasis and gene/environment interactions;
  • Primary and secondary prevention studies.

JCMT publishes high-quality original articles, reviews, case reports, commentaries, letters to editor, etc.

Ownership

The journal is owned by OAE Publishing Inc.

Publishing Model

Gold open access. All articles published by JCMT are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access.

Copyright and License to Publish

Articles in JCMT had been published under Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) by October 2017, whereas the Creative Commons Attribution 4.0 International (CC BY 4.0) was further adopted afterwards. The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.

Copyright is retained by authors. Authors are required to sign a License to Publish (which can be downloaded from the journal's Author Instructions), granting JCMT, which identifies itself as the original publisher, exclusive rights to publish their articles, and granting any third party the right to use the articles freely as long as the integrity is maintained and the original authors, citation details and publisher are identified.

Editorial Board

For more information about the editorial team, please refer to Editorial Board.

Peer Review

The journal adheres to a rigorous peer review process and undergoes single-blind peer review. For more details, please refer to Editorial and Peer Review Process and Peer Review Guidelines.

Publication Ethics Statement

Journal of Cancer Metastasis and Treatment is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines.

The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of Journal of Cancer Metastasis and Treatment take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.

Editorial Policies

All manuscripts submitted to JCMT should adhere to JCMT's Editorial Policies.

Journal Information and Statistics

  • Launch date: April 15, 2015 
  • Publication model: Open access 
  • ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)
  • Digital archive: Portico  
  • Frequency: Continuously published 
  • DOI: 10.20517/2394-4722 

Indexing & Archiving

Contact

Please see our Contact Us  page for details about different queries.

© 2016-2023 OAE Publishing Inc., except certain content provided by third parties